0000000001220256

AUTHOR

Luidmila Makovskaia

showing 1 related works from this author

Case of multifocal glioblastoma with four fusion transcripts of ALK, FGFR2, NTRK2, and NTRK3 genes stresses the need for tumor tissue multisampling f…

2021

Glioblastoma multiforme (GBM) is the most malignant brain tumor with patient mortality rate close to 100%, 5-yr survival rate of ∼5%, and a median survival of 14 mo. GBMs have notorious histomorphologic and molecular heterogeneities thus giving hope for development of future personalized therapies. We describe here a case of a 48-yr-old male patient with three-nodular GBM. To address the question of intratumoral molecular heterogeneity, a comparative analysis of gene expression was performed by using multiple samples collected from different tumor sites with the aid of intraoperative magnetic resonance imaging (MRI). Sixteen GBM biosamples from parietal, temporal, and temporo-polar localiza…

Research ReportMaleTemozolomideOncogene Proteins FusionBevacizumabBrain NeoplasmsglioblastomaRNAOncogenesGeneral MedicineMiddle AgedBiologyMagnetic Resonance ImagingTranscriptomeFusion transcriptGene expressionCancer researchmedicineHumansTranscriptomeGeneSurvival rateneoplasm of the central nervous systemmedicine.drugMolecular Case Studies
researchProduct